See the latest Coronavirus Information including testing sites, visitation restrictions, appointments and scheduling, and more.
Recognized by America's Top Doctors 2008 - 2018
Recognized by Best Doctors in America 2007 - 2018
Recognized annually in Philadelphia magazine's Top Docs issues, 1994 - 2020
Perelman Center for Advanced Medicine
Abramson Cancer Center, West Pavilion, 3rd Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
A facility of the Hospital of the University of Pennsylvania
Penn Medicine Cherry Hill
1865 Route 70 East
Cherry Hill, NJ 08003
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Farley J, Brady WE, Vathipadiekal V, Lankes HA, Coleman R, Morgan MA, , Mannel R, Yamada SD, Mutch D, Rodgers WH, Birrer M, Gershenson DM: Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or perineum: an open label, single-arm, phase 2 study. The Lancet 4(2):134-140 : 2013.
Myers SB, Manne SL, Kissane DW, Ozga M, Kashy DA, Rubin S, Heckman C, Rosenblum N, Morgan M, Graff JJ: Social-cognitive processes associated with fear of recurrence among women newly diagnosed with gynecologic cancers. Gynecol Oncol 128(1):120-127 : 2013.
Chu CS, Boyer J, Schullery DS, Gimotty PA, Gamerman V, Bender J, Levine BL, Coukos G, Rubin SC, Morgan MA, Vonderheide RH, June CH: Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission. Cancer Immunol Immunother 61(5):629-641. : 2012.
Morgan MA, Sill MW, Fujiwara K, Greer B, Rubin SC, DeGeest K, Yamada SD, Waggoner S, Coleman, RL, Walker JL, Mannel RS: A Phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in unreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study.
Gynecol Oncol 121(2):264-68 : 2011.
Greer BE, Koh WJ, Abu-Rustum NR, Apte SM, Campos SM, Chan J, Cho KR, , Copeland L, Crispens MA, DuPont N, Eifel PJ, Gaffney DK, Huh WK, Kapp DS, , Lurain JR, Martin L, Morgan MA, Morgan RJ, Mutch D, Remmenga SW, Reynolds RK, Small W, Teng N, Valea FA: Cervical Cancer. J Nat’l Compr Canc Netw 8(12):1388-416 : 2010.
Greer BE, Koh WJ, Abu-Rustum N, Bookman, MA, Bristow RE, Campos SM, Cho, KR, Copeland L, Crispens MA, Eifel PJ, Huh WK, Jagernauth W, Kapp DS, Kavanagh JJ, Lurain JR 3rd, Morgan MA, Morgan RJ, Powell CB, Remmenga SW, Reynolds RK, Alvarez Secord A, Small W Jr., Teng N.: NCCN Clinical Practice Guidelines in Oncology: Uterine Neoplasms.
J Natl Compr Canc Netw 7(5):498-531 : 2009.
Morgan MA, Polan ML, Melecot HH, Debru B, Sleemi A, Husain A: Experience with a low-pressure colonic pouch (Mainz II) urinary diversion for irreparable vesicovaginal fistula and bladder extrophy in East Africa. Int Urogynecol J 20:1163-1168 : 2009.
Morgan MA, Darcy KM, Rose PG, DeGeest K, Bookman MA, Aikins JK, Sill MW, Mannel RS, Allievi C, Egorin MJ: Paclitaxel poliglumex and carboplatin as first-line therapy in ovarian, peritoneal or fallopian tube cancer: A phase I and feasibility trial of the Gynecologic Oncology Group. Gynecologic Oncology 110:329-335 : 2008.
Morgan, MA: Intraperitoneal chemotherapy for ovarian cancer. Adv Exp Med Biol 622:145-51 : 2008.
Kavanagh JJ, Sill MW, Ramirez PT, Warshal D, Pearl ML, Morgan MA: Phase II multicenter open-label study of karenitecin in previously treated epithelial ovarian and primary peritoneal cancer: A Gynecologic Oncology Group Study. Int J Gynecol Cancer 18(3):460-464 : 2008.
Chief, Division Of Gynecologic OncologyUniversity Of Pennsylvania Health System3400 Civic Center Boulevard, 10th Floor PCAM South Tower
Patient appointments: 800-789-7366
Proton therapy is a non–invasive, incredibly precise cancer treatment that uses a beam of protons moving at very high speeds to destroy cancer cells.
Our experienced cancer nurses and referral staff are here to help. Call 800-789-7366 (PENN) or complete an online request.
Learn more about the benefits of translational research at Penn Medicine.